Redefining Cancer Diagnosis with AI-Driven Multi-Omics & Spatial Intelligence

Harnessing artificial intelligence and multi-omics integration to make cancer diagnosis faster, smarter, and more accurate - for every patient, everywhere.

Why invest in us

An Unmet Need. A Breakthrough Approach. A Massive Market Opportunity.

Other Firms

One-size-fits-all Approach

One-size-fits-all AI models that analyze only histology images, without integrating molecular data for deeper insights.

One-size-fits-all Approach

One-size-fits-all AI models that analyze only histology images, without integrating molecular data for deeper insights.

Rigid Algorithms that Limit Adoption

Rigid algorithms that attempt to replace pathologists rather than enhance clinical decision-making, limiting adoption.

Rigid Algorithms that Limit Adoption

Rigid algorithms that attempt to replace pathologists rather than enhance clinical decision-making, limiting adoption.

Lack of Adaptability

Lack of adaptability to real-world clinical workflows, often requiring additional infrastructure, training, and major workflow changes.

Lack of Adaptability

Lack of adaptability to real-world clinical workflows, often requiring additional infrastructure, training, and major workflow changes.

With PathMDAi

Multi-omics Integration

Multi-omics integration — combining histology with genomics, proteomics, and spatial data to deliver highly personalized, comprehensive diagnostic support.

Multi-omics Integration

Multi-omics integration — combining histology with genomics, proteomics, and spatial data to deliver highly personalized, comprehensive diagnostic support.

Designed to Empower

Designed to empower pathologists, not replace them, by fitting seamlessly into existing diagnostic workflows and improving consistency.

Designed to Empower

Designed to empower pathologists, not replace them, by fitting seamlessly into existing diagnostic workflows and improving consistency.

Compliance First

Federated AI and HIPAA-compliant architecture allow secure, scalable deployment across hospitals, labs, and research centers without disrupting existing infrastructure.

Compliance First

Federated AI and HIPAA-compliant architecture allow secure, scalable deployment across hospitals, labs, and research centers without disrupting existing infrastructure.

Our Papers

Being developed by scientists behind groundbreaking papers in nature, journal of precision medicine, and more

Our team

Meet the experts behind PathMDAi

Contact us

Shape Tomorrow’s Healthcare. Invest With Us Today